Clinical Trial Update: Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intra-hepatic administration of TheraSphere in combination with intravenous chemotherapy for cholangiocarcinoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Center Eugene Marquis | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED